Ten63 Therapeutics Company
Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the most lethal diseases. It combines low-residual, ML-based computational chemistry and mathematically guaranteed, superlinear search algorithms to find optimized drug candidates. The company's platform, COPPER, leverages its proprietary AI and state-of-the-art physical models to explore an unprecedentedly large chemical space, allowing them to discover new therapeutics to targets previously believed undruggable.
Founded Date:
2017-01-01
Last Funding Date:
2026-02-19
Industry:
Quantum Chemistry
Total Funding:
15900000
Headquarters:
Durham,North Carolina,United States,North America
Employee Number:
11-50
Funding Status:
private
Super Industry:
Quantum Science Applications
Funding Total Value:
15900000
Founders:
Jonathan Jou,Marcel Frenkel,Mark Hallen